Assuring safety without animal testing: The case for the human testis in vitro
Robert E. Chapin(Pfizer (United States)), Aldert H. Piersma(Utrecht University), Maarke J.E. Roelofs(Utrecht University), Ans M. M. van Pelt(Cliniques Universitaires Saint-Luc), Jorma Toppari(University of Turku), Kim Boekelheide(Brown University), Stefan Schlatt(University Hospital Münster), Bernard Jégou(Inserm), Emma L. Marczylo(Medical Research Council), Janine N. Post(University of Twente), Majorie B.M. van Duursen(Vrije Universiteit Amsterdam), Timothy W. Gant(Natural Environment Research Council), R. Cortvrindt, Katja J. Teerds(Wageningen University & Research)
Cited by 15
Related Papers
Male reproductive health and environmental xenoestrogens.
|Environmental Health Perspectives|1996|1.4k
Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility
|Physiological Reviews|2015|938
Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction
|Nature Biotechnology|2004|834
Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet
|Food and Chemical Toxicology|2003|797